SMTL ID : 5s9p.2 (3 other biounits)

CRYSTAL STRUCTURE OF THE FIRST BROMODOMAIN OF HUMAN BRD4 IN COMPLEX WITH 9-benzyl-2-(3,5-dimethyl-1,2-oxazol-4-yl)-7-(2-hydroxypropan-2-yl)-9H-carbazole-4-carboxamide

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 2.10 Å

Oligo State

monomer

Ligands

1 x YW4: 9-benzyl-2-(3,5-dimethyl-1,2-oxazol-4-yl)-7-(2-hydroxypropan-2-yl)-9H-carbazole-4-carboxamide(Non-covalent)

YW4.1: 17 residues within 4Å: Chain A: W.41, P.42, F.43, Q.45, P.46, V.47, D.48, K.51, L.52, L.54, Y.57, C.96, Y.99, N.100, D.105, I.106, M.109 13 PLIP interactions: 13 interactions with chain A Hydrophobic interactions: A:W.41, A:P.42, A:F.43, A:V.47, A:L.52, A:L.54, A:I.106 Hydrogen bonds: A:P.42, A:Q.45, A:D.48, A:N.100 Water bridges: A:C.96 pi-Stacking: A:W.41

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Gavai, A.V. et al., Discovery and Preclinical Pharmacology of an Oral Bromodomain and Extra-Terminal (BET) Inhibitor Using Scaffold-Hopping and Structure-Guided Drug Design. J.Med.Chem. (2021)

Release Date

2021-09-29

Peptides

Bromodomain-containing protein 4: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
B

Bromodomain-containing protein 4

Related Entries With Identical Sequence